|
CLINICAL PHARMACY / PRODUCT UPDATE STREAM | ||
  |
Preventing HIV transmission in Australia More than ever, community pharmacies are playing a key role in preventing and treating HIV. The introduction of PrEP after extensive Australian trials a few years ago has changed the way we think about sexual health in men who have sex with men. Pharmacist advice on the proper use of PrEP is vitally important for its efficacy and tolerability. Speaker: Brett MacFarlane, Senior Pharmacist, Australian College of Pharmacy |
 |
CLINICAL PHARMACY UPDATE: Queensland Pharmacy Needle & Syringe Program The Queensland Pharmacy Needle & Syringe Program aims to reduce the incidence of blood borne viruses and injecting related injuries and disease. This talk will discuss the value of the needle and syringe program in terms of cost-effectiveness, as well as the type of drugs and injecting equipment commonly used by those that frequent the program. Speakers: Dr Hidy Chan, Professional Practice Pharmacist - Pharmacy Needle & Syringe Program, The Pharmacy Guild of Australia, Queensland Branch |
|
CLINICAL PHARMACY UPDATE: Sleep apnoea - more than just a bad night’s rest Sleep apnoea is common, but still incompletely understood and underdiagnosed. Sleep apnoea has a significant effect on quality of life, but also on long term health outcomes. Pharmacists need to be able to identify potential cases of sleep apnoea and discuss the treatment options with patients. Speaker: Brett MacFarlane, Senior Pharmacist, Australian College of Pharmacy |
 |
CLINICAL PHARMACY UPDATE: UV protection - an essential update for pharmacists. Hear from a Queensland dermatologist on the topic of UV protection, with a focus on the frequently asked questions in pharmacy practice on UV protection and the science of sunscreens. By the end of the session, pharmacists should have greater confidence in answering tricky questions around filters, application and the environment. Speaker: Dr Samantha Davidson, Dermatologist |
 |
CLINICAL PHARMACY UPDATE: Herbal formula improves upper and lower gastrointestinal symptoms The “Gut Relief Study” run by the National Institute of Integrative Medicine (NIIM) in Melbourne shows that the Nutrition Care “NC Gut Relief” formula can reduce the frequency and severity of gastrointestinal symptoms by 60-80%. The study revealed significant improvements in gastrointestinal symptoms including indigestion, heartburn, nausea, constipation, diarrhoea, abdominal pain, stool consistency, gut microbiome, troublesome flatulence and bad breath. There were also evident improvements in quality of life, energy and sleep. Speaker: Associate Professor Dr Karin Ried, Director of Research, National Institute of Integrative Medicine |
 |
CLINICAL PHARMACY UPDATE: Osteoarthritis (OA) pain management – a critical role for pharmacists Recent changes in both Australian (RACGP) and UK (NICE) guidelines for management of OA, the imminent change in scheduling of modified- release paracetamol, changes in paracetamol overdose management and the latest information on the efficacy and safety of topical NSAIDs not only increase the need for pharmacist intervention, but provide the opportunity to enhance pharmacy’s professional role and develop business potential. This session will discuss these issues, explore what they mean for pharmacists and staff, and how evidence-based strategies can be best used to help patientsas well as pharmacy businesses. Speaker: John Bell, Community Pharmacist & Practitioner/Teacher, Graduate School of Health, University of Technology Sydney |
 |
CLINICAL PHARMACY UPDATE: Nutritional solutions for pain The International Association for the Study of Pain defines pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage”. Pain is a condition that is subjective and difficult to quantify, and therefore can be difficult to treat. This session will review the differences between acute and chronic pain and investigate the power of nutritional support, both in food and supplements, to help manage the symptoms of both types of pain. Speaker: Isabelle Baissac, Naturopath |
 |
CLINICAL PHARMACY UPDATE: Gut health, probiotics and improving immune health - what do we know? It is known that approximately 70% of the immune system is found in the digestive tract. Many researchers have identified key links between the gut microbiome and the immune system and an immune interaction is increasingly being recognised as a significant probiotic mechanism. This session aims to provide an update on the clinical data and explores the mechanism behind the interaction between the gut microbiome and the immune system. Speaker: Professor Georgina Hold, Researcher, Microbiome Research Centre, UNSW Sydney |
 |
The management of asthma is evolving in line with new evidence and strategies. Community pharmacists play an active and important role for patients suffering chronic respiratory diseases, such as asthma, through provision of health services in their pharmacy, diagnosing those at risk of disease progression and educating patients on the importance of medication compliance. This session will explore the latest guidelines from the National Asthma Council of Australia and the 2019 update of the Global Initiative for Asthma (GINA) global strategy. It will explore practical tools and resources to help pharmacists in delivering services, and the impact on improving health outcomes. Speaker: John Bell, Community Pharmacist & Practitioner/Teacher, Graduate School of Health, University of Technology Sydney |
|
CLINICAL PHARMACY UPDATE: Cow’s milk allergy Cows’ milk allergy in infants can be a challenge for parents and carers. Pharmacists have an important role to play in helping identify potential cases of cows’ milk allergy and helping families understand the management options. Speaker: Brett MacFarlane, Senior Pharmacist, Australian College of Pharmacy |
 |
Marketing in a downturn - survive and thrive during these times This is a concerning time for all. From supply chains, to tourism, to our teams on the ground in pharmacy, COVID-19 is affecting everyone, both professionally and personally. In times of trouble, pharmacy needs to listen deeply and be in tune with customer sentiment, and meet those needs with empathy and connection, across all channels including in- store and online. This session will highlight pharmacy needs and discuss some of the top fast, smart, affordable marketing strategies to drive business success as we traverse these challenging times. Speaker: Gillian Fish, Director The 6AM Agency |
 |
PRODUCT UPDATE: Product innovation - the lifeblood of pharmacy This session will explore an innovative new range of pharmacy-exclusive products which can help your pharmacy thrive in 2020. With advances in opioid-free pain relief emerging, an update on developments in day and night treatment options that will impact pharmacy will be provided, as well as an innovation on diarrhoea relief for children that offers relief for all the family and and which will help expand the category. Globally, liposomal technology is delivering consumer benefits in natural health and this session will reveal how Australian consumers and pharmacies can benefit from the power of the mighty liposome. Speaker: Daniel Shalhoub, Regional Sales Manager NSW/QLD, AFT Pharmaceuticals |
| |
CLINICAL PHARMACY UPDATE: Erectile dysfunction - a window on the heart Erectile dysfunction (ED) is common, and a cause of distress for many men. The cause of ED is often misunderstood by patients. So too is the fact that ED is related to a number of different serious health conditions. Pharmacists have an important role to play in advising on the correct use of ED medicines and lifestyle advice. Speaker: Brett MacFarlane, Senior Pharmacist, Australian College of Pharmacy |
 |
CLINICAL PHARMACY UPDATE: The Brain-Intestinal Mucosa-Appendix- Microbiome-Brain Loop The brain and the gut are connected from early foetal life. The mother’s exposure to microbial molecules is thought to exert in utero developmental effects on the foetus. These effects could importantly underpin the groundwork for subsequent pathophysiological mechanisms for achieving immunological tolerance and metabolic equilibrium post birth, events that continue through to 3-4 years of age. Bacteria promote cues that instruct the neonate’s mucosal tissues in the language of molecular and cellular biology. Post birth mucosal lymphoid tissue formation and maturation is microbiota-encouraged co- establishing the intestinal microbiome with a developing immune system. Speaker: Professor Luis Vitetta, Director of Medical Research, Medlab Clinical |
|
Driving Professional Services beyond CPA – Session 1 How do pharmacy health service offerings impact a customer’s journey to store loyalty? What is your pharmacy’s brand position and how can it be improved to really make your mark within the community? This two part session series will help you maximise your pharmacy’s health services income through meaningful customer interactions using real life examples encouraging attendees to implement immediate action. In session 1, we will explore the current state of industry and examples of what pharmacies are currently executing, plus explore the setting up and execution of a mental health service in pharmacy. Speaker: Michael Garrett, Business Support Pharmacist, The Pharmacy Guild of Australia, Queensland Branch |
|
Driving Professional Services beyond CPA – Session 2 How do pharmacy health service offerings impact a customer’s journey to store loyalty?
What is your pharmacy’s brand position and how can it be improved to really make your mark within the community? This two part session series will help you maximise your pharmacy’s health services income through meaningful customer interactions using real life examples encouraging attendees to implement immediate action. In session 2, we will build on our learnings from session 1 and look at how to successfully implement a vaccination service, including the total wrap around of health services a pharmacy can execute. We will also work through how to implement health services well, including the psychology of transitioning your team to be powerful health services advocates. Speaker: Michael Garrett, Business Support Pharmacist, The Pharmacy Guild of Australia, Queensland Branch |
 |
CLINICAL PHARMACY UPDATE: Can medicines causing constipation be deprescribed? Constipation is a commonly occurring functional gastrointestinal disorder which can cause serious consequences such as urinary incontinence and may cause or contribute to delirium in older people. The condition has been reported to occur in more than 50% of patients taking opioid analgesics for non-cancer pain and to become almost universal in palliative care patients. Commonly occurring adverse events associated with polypharmacy in elderly inpatients have included constipation in addition to arrhythmia, bleeding, orthostatic hypotension and seizures. Yet it may not be possible to deprescribe medicines causing constipation. Speaker: Dr Ben Basger, Clinical Pharmacist Medication Management, Wolper Jewish Hospital |
 |
Regulators, prescribers and users of compounded medicines continue to be concerned about the quality of medicines prepared in community pharmacies. The challenge most compounders face is how to provide adequate evidence that their products meet expectations of quality and safety in the same way as the commercial products registered by the TGA. One of the most valuable validation processes available to compounders is end product testing, but the process can at times be confusing. This session will explore the various testing procedures available to compounders, and provide simple protocols to enable pharmacists to implement a testing program for compounded preparations. Speaker: Marina Holt, Pharmacist & Education and Training Manager, PCCA |
 |
Human milk oligosaccharides are the third largest component in breast milk and serve numerous functions, in particular feeding and promoting optimal microbiome development in the breastfed infant. Recent advances have allowed milk oligosaccharides to be added to infant formula for the first time in Europe and the US. This session will provide an overview of the emerging evidence regarding the importance of human milk oligosaccharides for optimal infant microbiome development. Speaker: Dr Paula Smith-Brown, Dietitian & Microbiome Coach, Microba |
 |
CLINICAL PHARMACY UPDATE: Winter worries - when is it more than just a runny nose? This session will examine the role that pharmacy plays in alleviating parental concerns in this area. Specialist paediatrician Dr Jonny Taitz will also answer any questions on this increasingly important topic. Speaker: Dr Jonny Taitz, Specialist Paediatrician |
 |
PRODUCT UPDATE: Managing Acute Otitis Media (AOM) in children This session will provide an understanding of the prevalence and development of Acute Otitis Media (AOM) in Australian children, as well as the role antibiotics play in its recurrent nature. Gain the knowledge and tools needed to confidently recommend a probiotic by understanding the role in which specific probiotic strains have in the management and progression of Acute Otitis Media. Speaker: Amber Foley, Retail Education & Training Manager, Metagenics |
|
This session will provide you with the tools and techniques required to easily identify high quality ingredients, confidently select the appropriate products for your patient’s need or condition, and arm you with knowledge of common contraindications and tips of the trade. Attendees will leave with the information and tools needed to provide complementary medicine recommendations with confidence. Speaker: Amber Foley, Retail Education & Training Manager, Metagenics |
 |
CLINICAL PHARMACY UPDATE: Demystifying eyedrops Dry eye disease affects hundreds of millions of people throughout the world. Patients often report burning, stinging or tired eyes and often seek advice from pharmacists to recommend a product to help relieve their symptoms. Market research has shown that many patients assume their symptoms are just a part of life, and are unaware that they are suffering from a complex dry eye disease. Many of these patients may also visit a pharmacy to self-select treatment, but end up being confused by the wide range of artificial tears available on the market. This presentation will discuss common signs and symptoms of dry eye and how to identify which solution is best suited for each patient. Speaker: Anson Tang , Professional Affairs Associate, Alcon |
|
CLINICAL PHARMACY UPDATE: Wound care - now and in the future This session will provide an overview of the present and future role of community pharmacy in wound care, wound types and the basic management of wounds. The needs of residential age care facilities, including training needs, the impact of the MBS review and the Royal Commission on Ageing, will also be discussed. Speaker: Associate Prof Geoff Sussman, Wound Management Expert |
 |
CLINICAL PHARMACY UPDATE: Influenza update – current and future approaches This session will provide an update on current and future approaches towards seasonal influenza vaccines. Speaker: Dr Harsha Shetty, Senior Scientific Adviser for Influenza Vaccines, Seqirus Pty Ltd |
 |
This session will explore details of the new Cetaphil Face range, which has been dermatologically tested and clinically shown to be gentle on sensitive skin. The range has five products including a Gentle Foaming Cleanser, Extra Gentle Daily Scrub Cleanser, Daily Hydrating Lotion with Hyaluronic Acid, Rich Hydrating Night Cream with Hyaluronic Acid and a Hydrating Eye Cream. Speaker: Amy Lamproglou, Pharmacist |